Role of Human Immunodeficiency Virus Type 1 Integrase in Uncoating of the Viral Core

被引:43
|
作者
Briones, Marisa S.
Dobard, Charles W.
Chow, Samson A.
机构
[1] Univ Calif Los Angeles, Sch Med, Inst Mol Biol, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Sch Med, UCLA AIDS Inst, Los Angeles, CA 90095 USA
基金
美国国家卫生研究院;
关键词
TERMINAL CAPSID MUTANTS; CYCLOPHILIN-A; REVERSE TRANSCRIPTION; TRIM5-ALPHA RESTRICTION; HOST RESTRICTION; HIV-1; INFECTION; NUCLEAR IMPORT; MUTATIONS; PROTEIN; NEF;
D O I
10.1128/JVI.02382-09
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
After membrane fusion with a target cell, the core of human immunodeficiency virus type 1 (HIV-1) enters into the cytoplasm, where uncoating occurs. The cone-shaped core is composed of the viral capsid protein (CA), which disassembles during uncoating. The underlying factors and mechanisms governing uncoating are poorly understood. Several CA mutations can cause changes in core stability and a block at reverse transcription, demonstrating the requirement for optimal core stability during viral replication. HIV-1 integrase (IN) catalyzes the insertion of the viral cDNA into the host genome, and certain IN mutations are pleiotropic. Similar to some CA mutants, two IN mutants, one with a complete deletion of IN (NL-Delta IN) and the other with a Cys-to-Ser substitution (NL-C130S), were noninfectious, with a replication block at reverse transcription. Compared to the wild type (WT), the cytoplasmic CA levels of the IN mutants in infected cells were reduced, suggesting accelerated uncoating. The role of IN during uncoating was examined by isolating and characterizing cores from NL-Delta IN and NL-C130S. Both IN mutants could form functional cores, but the core yield and stability were decreased. Also, virion incorporation of cyclophilin A (CypA), a cellular peptidyl-prolyl isomerase that binds specifically to CA, was decreased in the IN mutants. Cores isolated from WT virus depleted of CypA had an unstable-core phenotype, confirming a role of CypA in promoting optimal core stability. Taken together, our results indicate that IN is required during uncoating for maintaining CypA-CA interaction, which promotes optimal stability of the viral core.
引用
收藏
页码:5181 / 5190
页数:10
相关论文
共 50 条
  • [21] Natural Polymorphisms of Human Immunodeficiency Virus Type 1 Integrase and Inherent Susceptibilities to a Panel of Integrase Inhibitors
    Low, Andrea
    Prada, Nicole
    Topper, Michael
    Vaida, Florin
    Castor, Delivette
    Mohri, Hiroshi
    Hazuda, Daria
    Muesing, Mark
    Markowitz, Martin
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (10) : 4275 - 4282
  • [22] ANALYSIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INTEGRASE MUTANTS
    ANSARILARI, MA
    DONEHOWER, LA
    GIBBS, RA
    VIROLOGY, 1995, 211 (01) : 332 - 335
  • [23] Characterization of Recombinant Integrase of Human Immunodeficiency Virus Type 1 (Isolate Bru)
    E. A. Semenova
    N. M. Gashnikova
    T. V. Il'ina
    T. R. Pronyaeva
    A. G. Pokrovsky
    Biochemistry (Moscow), 2003, 68 : 988 - 993
  • [24] HUMAN-IMMUNODEFICIENCY-VIRUS INHIBITORS TARGETED AT VIRUS-CELL FUSION AND OR VIRAL UNCOATING
    DECLERCQ, E
    INTERNATIONAL JOURNAL OF IMMUNOTHERAPY, 1992, 8 (03): : 115 - 123
  • [25] Irreversible inhibition of human immunodeficiency virus type 1 integrase by dicaffeoylquinic acids
    Zhu, K
    Cordeiro, ML
    Atienza, J
    Robinson, WE
    Chow, SA
    JOURNAL OF VIROLOGY, 1999, 73 (04) : 3309 - 3316
  • [26] INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INTEGRASE BY CURCUMIN
    MAZUMDER, A
    RAGHAVAN, K
    WEINSTEIN, J
    KOHN, KW
    POMMIER, Y
    BIOCHEMICAL PHARMACOLOGY, 1995, 49 (08) : 1165 - 1170
  • [27] Analysis of integration activity of human immunodeficiency virus type-1 integrase
    Kim, DJ
    Oh, YT
    Lee, SK
    Shin, CG
    MOLECULES AND CELLS, 1999, 9 (04) : 446 - 451
  • [28] Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase
    Gleenberg, Iris Oz
    Herschhorn, Alon
    Goldgur, Yehuda
    Hizi, Amnon
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2007, 458 (02) : 202 - 212
  • [29] Strategy to discriminate between high and low affinity bindings of human immunodeficiency virus, type 1 integrase to viral DNA
    Zargarian, L
    Benleumi, MS
    Renisio, JG
    Merad, H
    Maroun, RG
    Wieber, F
    Mauffret, O
    Porumb, H
    Troalen, F
    Fermandjian, S
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (22) : 19966 - 19973
  • [30] Posttranslational acetylation of the human immunodeficiency virus type 1 integrase carboxyl-terminal domain is dispensable for viral replication
    Topper, Michael
    Luo, Yang
    Zhadina, Maria
    Mohammed, Kevin
    Smith, Leonard
    Muesing, Mark A.
    JOURNAL OF VIROLOGY, 2007, 81 (06) : 3012 - 3017